Shandong Weigao boosts treasury holdings with share repurchase

Shandong Weigao Group Medical Polymer Company Limited (01066) announced a share repurchase on September 10, 2025. The company repurchased 720,000 H shares on the Exchange at a volume-weighted average price of HK$5.6775 per share, totaling HK$4,087,800.

This repurchase reduced issued shares (excluding treasury shares) by 720,000, bringing the new balance to 4,505,659,924. Concurrently, treasury shares increased by 720,000, raising the total to 16,672,400. This transaction represented 0.016% of the existing issued shares before the event.

The company's total issued shares remain at 4,522,332,324. This repurchase was executed under a mandate granted on May 27, 2025, which authorized the repurchase of up to 451,560,392 shares, representing 2.2199% of the issued shares at that time. To date, 10,024,000 shares have been repurchased under this mandate.